leema.ai

Medical Cannabis Healthcare

Health Tech & Life Sciences
Active
Pre-Seed Giv'atayim Founded 2020
Total raised
$200K
Stage
Pre-Seed
Founded
2020
Headcount
5
HQ
Giv'atayim
Sector
Health Tech & Life Sciences

About

Leema.ai is a digital health company that specializes in tailoring treatment plans for medical cannabis patients. Through its AI-powered platform, the company offers real-time insights, data-driven treatment recommendations, and continuous monitoring to enhance patient outcomes. Leema.ai has a demonstrated history of delivering effective treatment plans for more than 15,000 patients across Israel and the United States.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is leema.ai's primary focus?
Leema.ai is a digital health company specializing in tailoring treatment plans for medical cannabis patients using an AI-powered platform.
When was leema.ai founded?
Leema.ai was founded in June 2020.
How many patients has leema.ai served?
Leema.ai has delivered effective treatment plans for over 15,000 patients in Israel and the United States.
What is leema.ai's current funding stage?
Leema.ai is currently in the Pre-Seed funding stage.
What is the total amount of funding leema.ai has raised?
Leema.ai has raised a total of $200,000 USD.
In which accelerator program did leema.ai participate?
In November 2021, leema.ai was selected to participate in the BizLabs MedTech digital healthtech accelerator.
Who is a founder of leema.ai?
Dany Reiss is a founder of leema.ai.
What are leema.ai's key geographic markets?
Leema.ai operates in North America, Israel, Germany, the United Kingdom, Europe, France, and Canada.
How many employees does leema.ai have?
Leema.ai has 5 employees.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDigital HealthcareDigital Therapeutics
Technologies
Platforms & InterfacesMobile
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsConsumersRecreational & LifestyleCannabis
Business model
B2GB2B

Highlights

Verified

Tags

digital-therapeuticsclinical-trialscannabishealthcare-providersdigital-healthcarechronic-patientsmobile-applicationsinsurance-companiesmedical-cannabisdoctorspatients